DK481388A - Calciumtilskud - Google Patents

Calciumtilskud

Info

Publication number
DK481388A
DK481388A DK481388A DK481388A DK481388A DK 481388 A DK481388 A DK 481388A DK 481388 A DK481388 A DK 481388A DK 481388 A DK481388 A DK 481388A DK 481388 A DK481388 A DK 481388A
Authority
DK
Denmark
Prior art keywords
calcium
grants
malate
citrate
excipients
Prior art date
Application number
DK481388A
Other languages
Danish (da)
English (en)
Other versions
DK481388D0 (da
Inventor
Stephen Allen Jacobs
Original Assignee
Norwich Eaton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharma filed Critical Norwich Eaton Pharma
Publication of DK481388D0 publication Critical patent/DK481388D0/da
Publication of DK481388A publication Critical patent/DK481388A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/245Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/245Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265Citric acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK481388A 1987-08-28 1988-08-29 Calciumtilskud DK481388A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9081387A 1987-08-28 1987-08-28

Publications (2)

Publication Number Publication Date
DK481388D0 DK481388D0 (da) 1988-08-29
DK481388A true DK481388A (da) 1989-03-02

Family

ID=22224448

Family Applications (1)

Application Number Title Priority Date Filing Date
DK481388A DK481388A (da) 1987-08-28 1988-08-29 Calciumtilskud

Country Status (13)

Country Link
EP (1) EP0304987B1 (de)
JP (1) JP2795651B2 (de)
KR (1) KR970009583B1 (de)
AT (1) ATE82120T1 (de)
AU (1) AU625809B2 (de)
CA (1) CA1314233C (de)
DE (1) DE3875867T2 (de)
DK (1) DK481388A (de)
HK (1) HK182096A (de)
IE (1) IE61452B1 (de)
IL (1) IL87452A (de)
NZ (1) NZ225950A (de)
ZA (1) ZA886355B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0533724B1 (de) * 1990-06-14 1995-04-26 The Procter & Gamble Company Calciumcitrat/malat-gemisch
CA2102210C (en) * 1991-05-06 1998-08-04 Mark Benson Andon Combined calcium and vitamin d supplements
EP0622992B1 (de) * 1991-12-26 1998-10-14 The Procter & Gamble Company Lagerstabile getränkskonzentrate mit kalziumzusatz
US5389387A (en) * 1991-12-26 1995-02-14 The Procter & Gamble Company Storage stable calcium-supplemented beverage concentrates
CA2146632C (en) * 1992-10-21 1999-02-23 Alice Lyles Burkes Sweetener containing a concentrated bioavailable calcium source
CA2146633C (en) * 1992-10-21 1998-09-01 Mark Benson Andon Concentrated bioavailable calcium source
ES2089858T3 (es) * 1992-10-21 1996-10-01 Procter & Gamble Concentrados de premezcla para bebidas suplementados con calcio y estables en almacenamiento.
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
JPH09173020A (ja) * 1995-12-28 1997-07-08 Shiro Tanaka クエン酸・リンゴ酸カルシウムの可溶性濃厚カルシウム凍結品/冷蔵品およびその製造法
CN101505730B (zh) * 2006-08-17 2013-02-13 宝洁公司 包含柠檬酸苹果酸钙的组合物以及它们的制备方法
JP5140669B2 (ja) * 2006-08-17 2013-02-06 ザ プロクター アンド ギャンブル カンパニー クエン酸リンゴ酸カルシウムを含む組成物及びその製造方法
TR200908237A2 (tr) 2009-11-02 2011-05-23 Bi̇lgi̇ç Mahmut Kalsiyum ve D vitamini içeren farmasötik bileşimler.
CN104114179A (zh) * 2011-12-13 2014-10-22 艾玛菲克有限公司 用于治疗钙吸收不良和骨代谢紊乱的无定形碳酸钙
CN107921060A (zh) 2015-06-04 2018-04-17 艾玛菲克有限公司 用于吸入施用、舌下施用或含服施用的无定形碳酸钙的组合物
IL294615A (en) 2016-10-25 2022-09-01 Amorphical Ltd Amorphous calcium carbonate for the treatment of leukemia
CN112137787B (zh) * 2020-09-16 2023-01-06 张宏伟 一种足踝外科下胫腓关节复位固定导向器

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5697248A (en) * 1979-12-28 1981-08-05 Tanaka Shiro Conjugated compound of calcium citrate and calcium malate and its preparation
FR2601249A1 (fr) * 1986-07-09 1988-01-15 Sandoz Lab Nouvelles compositions pharmaceutiques a base de sels de calcium.
US4786510A (en) * 1987-07-02 1988-11-22 The Procter & Gamble Company Calcium-iron mineral supplements
CA1319612C (en) * 1987-07-02 1993-06-29 Haile Mehansho Iron-calcium mineral supplements with enhanced bioavailability

Also Published As

Publication number Publication date
DE3875867D1 (de) 1992-12-17
KR970009583B1 (en) 1997-06-14
DE3875867T2 (de) 1993-04-01
ATE82120T1 (de) 1992-11-15
IE882610L (en) 1989-02-28
EP0304987A2 (de) 1989-03-01
CA1314233C (en) 1993-03-09
EP0304987A3 (en) 1990-02-21
JPH01156985A (ja) 1989-06-20
IE61452B1 (en) 1994-11-02
KR890003391A (ko) 1989-04-14
ZA886355B (en) 1989-05-30
AU625809B2 (en) 1992-07-16
EP0304987B1 (de) 1992-11-11
NZ225950A (en) 1991-10-25
HK182096A (en) 1996-10-11
AU2159888A (en) 1989-06-15
JP2795651B2 (ja) 1998-09-10
DK481388D0 (da) 1988-08-29
IL87452A0 (en) 1989-01-31
IL87452A (en) 1992-07-15

Similar Documents

Publication Publication Date Title
DK481388A (da) Calciumtilskud
IL84425A (en) (s) - (+) -ibuprofen-containing pharmaceutical compositions
IL83510A0 (en) Pharmaceutical compositions containing dipyridamole or mopidamol and o-acetylsalicylic acid or salts thereof and their preparation
EP0494972A4 (en) Effervescent dosage form and method of administering same
IL103213A (en) Medicaments for treating gastrointestinal disorders containing ranitidine bismuth citrate together with certain helicobacter pylori-inhibiting antibiotics
SE9002500D0 (sv) Farmaceutisk, nac-innehaallande komposition foer oral administrering
DK0389035T3 (da) Farmaceutisk præparat der indeholder en farmaceutisk egnet bærer og forbindelsen med strukturen (7alfa,17alfa)-17-hydroxy-7-methyl-19-nor-17-pregn-5-(10)-en-20-yn-3-on
KR890003390A (ko) 골다공증 및 관련된 장해의 치료방법
GR1000419B (el) Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου.
DE3686022D1 (de) Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
PT86205A (en) Process for the preparation of 3-]omega-(3,5-di-t-butil-4-hydroxyphenyl)-alkanoyl"pyrroles and their de-oxy analogs useful in therapy
IT1215332B (it) Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
ATE59550T1 (de) Chlorpheniramine therapie.
IT1224250B (it) Associzione del depiprazolo con la morfina
IL79207A0 (en) Pharmaceutical compositions containing terguide
DE3786168D1 (de) Verwendung von para-aminobenzoesaeure zur herstellung eines arzneimittels zur bekaempfung von photoallergien.
ATE72397T1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment